[Angiogenesis targeting in renal carcinomas].

Abstract:

:Angiogenesis targeting with inhibitors of VEGF receptors is currently modifying in depth the treatment strategy of metastatic clear cell renal carcinoma. Although immunotherapy remains prescribed in selected patients with good prognosis, sunitinib and sorafenib are presently the most active agents in this malignancy. The results available, in terms of response as in terms of progression-free survival, argue in favour of the use of sunitinib in first line. The two agents have distinct toxicity profiles, which may lead in the future to select the treatment as a function of an individual patient basis. Preliminary results suggest the possibility of partial cross-resistance between them.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Pouessel D,Culine S

subject

Has Abstract

pub_date

2007-01-01 00:00:00

pages

F223-6

issue

7 Suppl

eissn

0007-4551

issn

1769-6917

journal_volume

94

pub_type

杂志文章,评审
  • Expression of class III beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy.

    abstract::This study determined the prevalence and the prognostic value of the expression of microtubule components in tumors of 19 patients with non small cell lung cancer receiving taxane-based regimens. Patient samples were stained with antibodies directed against total beta tubulin, classes I, II and III beta tubulin isotyp...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Dumontet C,Isaac S,Souquet PJ,Bejui-Thivolet F,Pacheco Y,Peloux N,Frankfurter A,Luduena R,Perol M

    更新日期:2005-02-01 00:00:00

  • [Treatment with cytokines of metastatic kidney cancer: the Lyon experience].

    abstract::Between October 1987 and June 1992, 244 patients with metastatic renal carcinoma were referred to our Institute. One hundred and sixty-nine were included in immunotherapy protocols. The 40 most recent patients were included in the ongoing multicentric randomised Crecy study. The previous patients were treated with IL2...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Négrier S,Mercatello A,Coronel B,Lanier F,Merrouche Y,Bret M,Blay JY,Lasset C,Thiesse P,Carrie C

    更新日期:1993-07-01 00:00:00

  • [Cell cycle and molecular targets: CDK inhibition].

    abstract::Protein phosphorylation is a fundamental post-translational modification. It regulates a large number of critical cellular processes (differentiation, division, proliferation, apoptosis). Cell division is a process including a series of phases by which a parent cell divides into two daughter cells. The cells enter the...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1383

    authors: Carassou P,Meijer L,Le Moulec S,Aoun J,Bengrine-Lefèvre L

    更新日期:2012-02-01 00:00:00

  • [The CAR-T cells are here].

    abstract::Due to immunotherapy, a new era of treatment is opening up for the treatment of solid cancers and hematological tumors. T cells genetically modified with a chimeric antigen receptor (CAR-T cells) have recently been proved efficient in hematological malignancies expressing CD19. On June 20th 2018, the European Medicine...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2018.08.001

    authors: Croizier C,Douge A,Bay JO,Lemal R

    更新日期:2018-09-01 00:00:00

  • [Prevalence of cancer, health care and daily life assistance in people aged 75 or over living in the Tarn area (France)].

    abstract::The association between cancer and dependence was estimated using a cross-sectional study among persons 75 years of age or-older in Tarn county (area with a cancer registry recognized by the National Committee of Registries). A representative random sample stratified on age, sex, and size of district, was drawn using ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Faliu B,Berthier F,Grosclaude P,Aptel I,Cayla F,Machelard-Roumagnac M,Duchene Y

    更新日期:1997-02-01 00:00:00

  • [Prostate cancer and chemotherapy].

    abstract::Androgen deprivation in patients with metastatic prostate cancer produces palliation of symptoms, PSA decrease and tumoral regression in most patients. After a brief period of disease regression lasting 18 to 24 months nearly all pts will progress to androgen independence disease (HRPC) with progressive clinical deter...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Gravis G,Salem N,Bladou F,Viens P

    更新日期:2007-07-01 00:00:00

  • [P53 genes and solid tumors].

    abstract::The p53 gene is known to play a central role in cancer. In fact, no human tumor type is devoid of p53 mutations, although differences can be seen in the relative frequencies and patterns of nucleotide substitutions. Our work illustrates these differences, since frequencies of mutations ranged from 15 to 80% and the pa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Theillet C

    更新日期:1993-08-01 00:00:00

  • [Ondansetron: a specific 5-HT3 serotonin receptor inhibitor, a new antiemetic in oncology].

    abstract::Serotonin (5-Hydroxytryptamine) seems to play a dominant role in triggering vomiting induced by cytotoxic agents through the stimulation of 5-HT3 receptors. They have been observed in the GI tract as well as in the brain (area postrema). Ondansetron is a specific antagonist of 5-HT3 serotonin receptors. Its anti-emeti...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: d'Allens H,Aubert B,Bons J,Pappo M

    更新日期:1991-01-01 00:00:00

  • [Integrins, cell response to anti-tumor agents and chemoresistance].

    abstract::Integrins are a family of heterodimeric transmembrane receptors that mediate cell-cell and cell-extracellular matrix adhesion. Integrin-mediated signaling is essential for the regulation of fundamental cellular functions, including proliferation and survival, and for tumor development. According to in vitro studies, i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Maubant S,Staedel C,Gauduchon P

    更新日期:2002-11-01 00:00:00

  • [Nomograms in routine clinical practice: Methodology, interest and limitations].

    abstract::In order to help the clinician, mathematical models including several clinical and pathological variables are proposed in the literature with the aim to predict the occurrence of an event of interest. Nomograms allow individual prognosis for each patient. When they are developed, validated and correctly used, nomogram...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2017.10.024

    authors: Filleron T,Chaltiel L,Jouve E,Cabarrou B,Gilhodes J,Lusque A,Mery E,Dalenc F,Martinez A

    更新日期:2018-01-01 00:00:00

  • [SOR SAVOIR PATIENT Cancer and fatigue. Information dedicated to cancer patients and relatives].

    abstract::In response to the evolution of the information-seeking behaviour of patients and concerns from health professionals regarding cancer patient information, the French National Federation of Comprehensive Cancer Centres (FNCLCC) introduced, in 1998, an information and education program dedicated to patients and relative...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Dielenseger P,Dilhuydy JM,Brusco S,Chazot L,Blay JY,Bové B,Colcanap B,Ferrandez JC,Floquet A,Jane Gledhill,Hubert N,Meslier M,Rosman S,Carretier J,Delavigne V,Fervers B,Leichtnam-Dugarin L,Philip T,Standards, Options

    更新日期:2006-12-01 00:00:00

  • [Pharmacological consequences of the targeting of epidermal growth factor receptor].

    abstract::Through clearly identified molecular mechanisms, EGFR targeting leads to cell physiology modifications as cell proliferation, apoptosis and DNA repair. These mechanisms can explain the proper activity of EGFR targeting drugs but also represent a strong rational basis on which several experimental studies have been des...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Milano G,Magné N

    更新日期:2003-11-01 00:00:00

  • [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].

    abstract::The biological behaviour of invasive carcinoma of the uterine cervix is not always predictable. It is therefore important to establish new biological markers which could be useful in determining a more reliable prognosis. We have analyzed the c-Ha-ras and c-myc proto-oncogenes in a large series (154 cases) of cervical...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Riou G,Sheng ZM,Zhou D,Lusinchi A,Le Doussal V,Barrois M

    更新日期:1990-01-01 00:00:00

  • [Gemcitabine and breast cancer].

    abstract::Gemcitabine has demonstrated a good efficacy in number of tumor types. Thanks to its favourable toxicity profile, gemcitabine can be used in combination with a number of drugs. Single agent gemcitabine and gemcitabine-based combinations have been evaluated in metastatic breast cancer. Some of these combinations, such ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Besse B,Spano JP

    更新日期:2002-08-01 00:00:00

  • [Colorectal cancer in the elderly].

    abstract::Colorectal cancer occurs after the age of 75 in 50% of the case, but elderly patients are under-treated and far from an optimal management of their disease. Principles of colorectal cancer management after the age of 75 are theoretically the same than for younger patients, but physiological age, comorbidities and pati...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2007.0545

    authors: Mitry E

    更新日期:2008-05-28 00:00:00

  • Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in The Netherlands: how far have we come?

    abstract::By the genetic localization of the first melanoma susceptibility gene on chromosome 1p we thought that the puzzle on familial melanoma families would soon be solved. Now, almost fifteen years later we have learned that inherited melanoma is not a simple genetic disorder and that multiple genes, modifying genes and env...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Gruis NA,Van der Velden PA,Bergman W,Frants RR

    更新日期:1998-07-01 00:00:00

  • 4-methylthio 2-oxobutanoate transaminase: a specific target for antiproliferative agents.

    abstract::We have previously shown that the addition of 4-methylthio-2-oxobutanoate (MTOB) to cultures of methionine dependent neoplastic cells which lack endogenous MTOB restores their capacity to grow in the absence of exogenous methionine. Transition state inhibitors of the MTOB transaminase,responsible for the transaminatio...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Quash G,Roch AM,Charlot C,Chantepie J,Thomas V,Hamedi-Sangsari F,Vila J

    更新日期:2004-04-01 00:00:00

  • [Novel conventional therapies in onco-hemathology].

    abstract::Cytogenetic, molecular and phenotyping features of malignant hematologic diseases succeeded in improving their management by a more accurate stratification of patients according to several groups of risk and by providing a rational for targeted therapy. Three major types of treatment (excluding cellular therapy) are c...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1412

    authors: Baleydier F,Domenech C,Thomas X

    更新日期:2011-08-01 00:00:00

  • [10-year retrospective analysis of the sequelae of loco-regional treatment of breast cancer].

    abstract::With a minimum follow-up period of 10 years, the incidence of sequelae after loco-regional treatment of 349 breast cancers remains low, being dominated by lymphoedema. Rare after treatment by irradiation alone, lymphoedema appears more frequently in patients treated by radio-surgical association, in spite of a moderat...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Calitchi E,Cheula JM,Otmezguine Y,Roucayrol AM,Mazeron JJ,Le Bourgeois JP,Pierquin B

    更新日期:1984-01-01 00:00:00

  • [Genetic instability as a driver for oncogenesis].

    abstract::Genomic DNA displays a non canonical structure prone to be damaged and modified by genotoxic stresses, which are induced either by the endogenous metabolism or attacks from environment or therapeutic pressure. Several molecular pathways allow cells to repair such DNA lesions. Additional mechanisms have been selected t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1202

    authors: Cazaux C

    更新日期:2010-11-01 00:00:00

  • [Cell signalling and cancer].

    abstract::Cell signalling represents the network of cell communication pathways. Reception of a message by a cell results in the implementation of various direct and indirect actions, especially through the transcription of the genes required for carrying out the orders received. The signals exchanged by cells may concern proli...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1199

    authors: Robert J

    更新日期:2010-11-01 00:00:00

  • [The contribution of PET to radiation treatment planning].

    abstract::Advances in medical imaging have greatly enhanced the speciality of radiation oncology by allowing more healthy tissue to be speared for better tumour coverage. Positron emission tomography (PET) with the glucose analogue [18F]-fluoro-2-deoxy-D-glucose (FDG) is a functional imaging method that has become widely used i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Belkacémi Y,Lartigau E,Kerrou K,Carpentier P,Taïeb S,Giraud P

    更新日期:2007-01-01 00:00:00

  • Cost-effectiveness analysis for clinical procedures in oncology.

    abstract::The provision of medical care consumes resources, and the resources available for the provision of medical care are limited. Decisions are being made at many levels of the Health Care System, including providers and fiscal intermediaries, to allocate these resources. Such decisions, however, are often inconsistent wit...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Weinstein MC

    更新日期:1980-01-01 00:00:00

  • [Role of [18F]-FDG PET-CT in the management of the head and neck cancers].

    abstract:OBJECTIVES:To evaluate the impact of [(18)F]-FDG PET/CT image fusion in the management of carcinomas of the upper aero-digestive tract. METHODS:This retrospective study included 169 patients with squamous cell cacinoma of the upper aerodigestive tract who underwent a PET/CT for : initial staging (n = 47), cervical lym...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Fakhry N,Barberet M,Lussato D,Cammilleri S,Mundler O,Giovanni A,Zanaret M

    更新日期:2006-10-01 00:00:00

  • Image guided radiotherapy for prostate cancer.

    abstract::The purpose of external beam radiotherapy is to sterilize malignant tumours and at the same time to avoid complications by radiation injury to the surrounding healthy tissues. Modern radiation techniques in recent years have allowed to safely escalate the dose by approximately 10% for the treatment of prostate cancer,...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0599

    authors: Soete G,Verellen D,Storme G

    更新日期:2008-03-01 00:00:00

  • [Symptomatic management of brain metastasis].

    abstract::Indications and choice of antiepileptic drugs (AED), treatments for cerebral edema and prophylactic and curative treatments of thromboembolic complications of brain metastasis are discussed. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1689

    authors: Le Rhun E,Taillandier L,Beauchene P,Bailon O,Dubois F

    更新日期:2013-01-01 00:00:00

  • [Renovascular effects of antiangiogenic drugs].

    abstract::During the last decade, inhibitors of the vascular endothelial growth factor (VEGF) were developed for the treatment of cancer. Many anti-VEGF are available but the issue is still the same: to inhibit the effect of the VEGF on their receptors. There are two main classes, depending on the mechanism of action by blockin...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.05.005

    authors: Deray G,Janus N,Aloy B,Launay-Vacher V

    更新日期:2016-07-01 00:00:00

  • [Neoadjuvant chemotherapy FEC-HD in locally advanced breast cancer].

    abstract::The tolerance and the clinical and histological efficacy of a neoadjuvant chemotherapy FEC-HD including hematopoietic growth factors have been studied in 40 patients with stade II or III breast cancer between February 1991 and February 1997. Four courses were given, every 21 days, with 5-fluorouracil (750 mg/m2/day D1...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Darut-Jouve A,Coudert B,Jolimoy G,Belichard C,Arnoud L,Guerrin J

    更新日期:1999-02-01 00:00:00

  • [Prerequisite for hematopoietic cellular therapy programs to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::CAR T-cells are autologous or allogeneic human lymphocytes that are genetically engineered to express a chimeric antigen receptor targeting an antigen expressed on tumor cells such as CD19. CAR T-cells represent a new class of medicinal products, and belong to the broad category of Advanced Therapy Medicinal Products ...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引

    doi:10.1016/j.bulcan.2017.10.017

    authors: Yakoub-Agha I,Ferrand C,Chalandon Y,Ballot C,Castilla Llorente C,Deschamps M,Gauthier J,Labalette M,Larghero J,Maheux C,Moreau AS,Varlet P,Pétillon MO,Pinturaud M,Rubio MT,Chabannon C

    更新日期:2017-12-01 00:00:00

  • [Interest of studying the in vitro genotoxicity of an antineoplastic drug on healthy human cells: paclitaxel example].

    abstract::Paclitaxel is often used as an adjuvant antineoplastic agent. However, very little data is available in literature on its potential genotoxicity on healthy human cells. Our objective is to study the potential in vitro genotoxicity of paclitaxel, by using the cytokinesis-blocked micronucleus assay in combination with f...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Digue L,Orsière T,Baciuchka-Palmaro M,Duffaud F,Pompili J,Favre R,Botta A

    更新日期:2002-10-01 00:00:00